Comparison - BIO - NYSE - Weiss Ratings

Weiss Ratings	BIO - NYSE	Click to Compare	Click to Compare	Click to Compare
Rating	D
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D
Reward Grade	E

Rating Factors	BIO - NYSE	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Weak
Efficiency Index	Very Weak
Solvency Index	Excellent
Total Return Index	Weak
Volatility Index	Weak

Beta / Standard Deviation	BIO - NYSE	Click to Compare	Click to Compare	Click to Compare
Beta	1.10

Price History	BIO - NYSE	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	-2.07%
30-Day Total Return	-31.57%
60-Day Total Return	-26.46%
90-Day Total Return	-24.28%
Year to Date Total Return	-23.00%
1-Year Total Return	-25.53%
2-Year Total Return	-48.61%
3-Year Total Return	-53.59%
5-Year Total Return	-21.52%
52-Week High % Change	-35.31%
52-Week Low % Change	2.79%

Price	BIO - NYSE	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$387.99
52-Week Low Price	$244.19
52-Week Low Price (Date)	Mar 10, 2025
52-Week High Price (Date)	Nov 06, 2024

Valuation	BIO - NYSE	Click to Compare	Click to Compare	Click to Compare
Market Cap	8.01B
Enterprise Value	7.72B
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-65.04
Earnings Per Share Growth	202.54%
Price/Earnings To Growth	--
Price/Sales (TTM)	2.74
Price/Book (Q)	1.07
Enterprise Value/Revenue (TTM)	3.01
Price	$251.13
Enterprise Value/EBITDA (TTM)	18.11
Enterprise Value/EBIT	28.10
Market Cap Category	Mid Cap

Dividends and Shares	BIO - NYSE	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	28.00M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	BIO - NYSE	Click to Compare	Click to Compare	Click to Compare
Phone Number	510 724 7000
Address	1000 Alfred Nobel Drive Hercules, CA 94547
Website	www.bio-rad.com
Country	United States
Year Founded	1952

Profitability	BIO - NYSE	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	10.70%
Profit Margin	-71.85%

Management Effectiveness	BIO - NYSE	Click to Compare	Click to Compare	Click to Compare
Return on Assets	1.59%
Return on Equity	--

Income Statement	BIO - NYSE	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	2.57B
Total Revenue (TTM)	2.57B
Revenue Per Share	$91.67
Gross Profit (TTM)	1.38B
EBITDA (TTM)	426.40M
EBIT (TTM)	274.80M
Net Income (TTM)	-1.84B
Net Income Avl. to Common (TTM)	-1.84B
Total Revenue Growth (Q YOY)	-2.00%
Earnings Growth (Q YOY)	-304.67%
EPS Diluted (TTM)	-65.04
EPS Diluted Growth (Q YOY)	-310.69%

Balance Sheet	BIO - NYSE	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	1.66B
Cash Per Share (Q)	$59.45
Total Current Assets (Q)	3.03B
Total Preferred Equity (Q)	--
Total Equity (Q)	6.57B
Current Ratio (Q)	6.478
Book Value Per Share (Q)	$234.52
Total Assets (Q)	9.36B
Total Current Liabilities (Q)	467.80M
Total Debt (Q)	1.37B
Total Liabilities (Q)	2.79B
Total Common Equity (Q)	6.57B

Cash Flow	BIO - NYSE	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	-160.20M
Cash from Financing (TTM)	-218.80M
Net Change in Cash (TTM)	85.40M
Levered Free Cash Flow (TTM)	153.80M
Cash from Operations (TTM)	455.20M